DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Imatinib Mesylate is a drug marketed by Amneal Pharms, Apotex, Breckenridge, Dr Reddys, Eugia Pharma, Hikma Pharms, Mylan, Natco Pharma Ltd, Shilpa, Sun Pharm, Teva Pharms Usa, Wockhardt Bio Ag, and Zydus Pharms. and is included in thirteen NDAs.
The generic ingredient in IMATINIB MESYLATE is imatinib mesylate. There are thirty-four drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the imatinib mesylate profile page.
A generic version of IMATINIB MESYLATE was approved as imatinib mesylate by SUN PHARM on December 3rd, 2015.
Summary for IMATINIB MESYLATE
Recent Clinical Trials for IMATINIB MESYLATE
Identify potential brand extensions & 505(b)(2) entrants
|First Affiliated Hospital of Wenzhou Medical University||Phase 2|
|Zhejiang Cancer Hospital||Phase 2|
|Second Affiliated Hospital, School of Medicine, Zhejiang University||Phase 2|